本文检索2014年之前治疗II型糖尿病的传统药物发明专利，得到共1 229件专利族信息。从专利的授权情况、发展趋势、地域分布、竞争国家、竞争机构、技术重点、药材偏好等方面对其进行了整体层面的统计和分析，结果显示，中国在专利申请数量上处于领先地位，高等院校、科研院所和药企是申请主体。虽然治疗糖尿病的学说和流派众多，在申请专利保护的中药复方上，多以益气养阴清热为主，使用频次前20位的药物多为补虚药和清热药。本研究展现了传统药物治疗糖尿病的发展历史和临床使用的整体思路，由此分析治疗糖尿病传统药物的研究、开发、应用导向，可帮助研究者了解治疗糖尿病中药的研发成果和专利格局，指导未来研究方向。

In this paper, the patent of traditional medicines of type-2 diabetes mellitus before 2014 were searched, totally 1 229 patent family information were obtained. The patent information including developing trends, geographic distribution, competitive agencies, technical focus, herbs preferences and so on were analyzed. China is in a leader position on the number of applying patent of using traditional medicine to treat type-2 diabetes mellitus, and the main applications were research institutes, universities and pharmaceutical enterprises. Although the views and theories on treatment of type-2 diabetes mellitus are variety and abound, the most frequently used traditional medicines are tonics and heat-clearing. This article reflected the history, clinical treatment way, developments, application of the diabetes traditional drugs after a meta-analysis, efforts to guide a better understanding and further research.

国家自然科学基金委面上项目（81274188）：四种别样茶改善胰岛素抵抗的物质基础和作用机制研究，负责人：许利嘉。